Latest Drug Safety news
FDA Sends 100 Cease-and-Desist Letters in Crackdown on DTC Drug Advertisements
posted September 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Creates “Green List” of GLP-1 Drug Ingredients Approved for Entry in the U.S.
posted September 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA
posted August 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Requiring Stronger Safety Labels for Opioid Medications
posted August 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Withdrawal From Medetomidine Increasingly Seen in ICUs .jpg)
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder 
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl 
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia Related Articles
Unintentional Ingestion of Recreational Drugs Increased, Especially Since 2013 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs Monthly Specialist Briefings
Stay Connected
